AKT1 and breast cancer: In our study, the levels of p-PI3K/PI3K and p-AKT/AKT were significantly decreased by SASH1 overexpression, suggesting that SASH1 blocks the malignant biological behaviors of breast cancer cells through the inhibition of PI3K/AKT signaling pathway.